logo-loader
viewOpen Orphan PLC

Open Orphan coronavirus testing machine arrives at hVivo's east London lab

The new kit has the capacity to perform 3,000 tests per day

Open Orphan PLC -

Open Orphan PLC (LON:ORPH) has confirmed that its coronavirus COVID-19 Antibody Microarray machine is on-site at hVivo's laboratory in east London and is undergoing testing.

The move follows the company’s recently announced tie-up with Quotient Limited. The machine, which will be fully operational in two weeks, can carry out 3,000 tests per day.

In Monday's update, Open Orphan also said it is in discussions with channel partners to secure new business.

“It is the intention to supply testing capability to channel partners, who will in turn deal with the end users and the final price points,” the company said.

Currently, home kits are retailing for £70-£150 each.

Quick facts: Open Orphan PLC

Price: 14.25 GBX

AIM:ORPH
Market: AIM
Market Cap: £78.24 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Open Orphan PLC named herein, including the promotion by the Company of Open Orphan PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Open Orphan's Cathal Friel on its £12mln raise to accelerate coronavirus...

Open Orphan PLC's (LON:ORPH) Cathal Friel speaks to Proactive London's Andrew Scott after announcing they've raised approximately £12mln to ramp up its coronavirus (COVID-19) antiviral testing. Friel says the fundraise has brought many new leading blue-chip institutional shareholders to their...

3 days, 12 hours ago

2 min read